Right Turn: SOPs, PPE and the DNA of lab life

by Stacey Johnson | Sep 27, 2019

If you have ever visited an academic or industry lab, you will be taught about the protocols for that lab. Even in high school, there are strict rules to follow and ways to behave and dress around lab materials. What you are required to wear is called Personal...

Summer by Design: Filling in the gap between academia and industry

by Guest | Sep 18, 2019

Virginia Palomares Cabeza is a fourth-year PhD candidate at the Erasmus Medical Centre (Rotterdam, the Netherlands) and the University College Dublin (Ireland). Her interdisciplinary research focuses on investigating the immune responses of allogeneic stem cell...

Breathing new life into gut regeneration with living bandages

by Erika Siren | Sep 11, 2019

At first pass, the skin and the gut are not so different: both are lined with an outer layer of cells that serve as the first line of protection from biological, chemical and physical wear-and-tear. Accordingly, both the gut and skin are subject to tissue breakdown...

Right Turn: Trend watching in biotherapeutics

by Stacey Johnson | Sep 6, 2019

The field of biotherapeutics – treatments produced by, or involving, living cells – is quickly evolving with the popularity and pursuit of new cell therapies. If you’re a student or young professional working in this space, you know this already. But how familiar are...

Right Turn: Recharging

by Stacey Johnson | Aug 30, 2019

Hi Signals readers, We hope you’ve had a great summer and enjoyed all of our posts so far in 2019. There is still lots to come, but we’re on vacation this week so we can recharge and come back in September full of energy and brimming with fresh ideas. May...

Blog Carnival: Because we all want to see life-saving cell and gene therapies saving lives

by Stacey Johnson | Aug 21, 2019

Cell and gene therapies are a game changer for patients. As academics and industry have been saying for years now, these therapies offer the promise of cures for previously incurable diseases and disorders. There were over 1,000 clinical trials underway worldwide at...

Bringing innovative cell and gene therapy products to Canadians

by Guest | Aug 21, 2019

Siofradh McMahon is Senior Manager, Clinical Translation and Regulatory Affairs at CCRM. Síofradh works with academic and industry partners to advance promising products and technologies to commercialization. Having worked worldwide, Síofradh brings more than a decade...

How to advocate for science this fall – using the #VoteScience campaign

by Farah Qaiser | Aug 15, 2019

Science doesn’t usually get a lot of attention during elections, and we think that this needs to change. That’s why, on August 8th, a coalition of science groups, including Evidence For Democracy, the Toronto Science Policy Network (TSPN) and the Science & Policy...

Science matters. Stand up for science!

by Stacey Johnson | Aug 14, 2019

Canadian science groups and a non-partisan organization that promotes the “transparent use of evidence in government decision-making in Canada” have come together to launch a national campaign before Canadians go to the polls this fall to elect their federal...

Business of Regenerative Medicine Conference 2019: The rundown

by Guest | Aug 8, 2019

Matthew Mistry is a Market and Equity Analyst at CCRM, where he conducts investment diligence, market analyses, participates in company creation activities and supports strategic business development. He joined CCRM from the Ontario Bioscience Innovation Organization...